Although the multi-omics bioinformatics analysis indicated that CCT6A could function as a biomarker for CRC and had prognostic value, some deficiencies still need to be covered by experimental investigations, such as the modulation of CCT6A on cell proliferation/migration and the intrinsic mechanism in CRC. The gene discussed is CCT6A; the disease is colorectal carcinoma.